A maker of women's health medicines, it developed the brands Annovera, a vaginal contraceptive, and BIJUVA and IMVEXXY, hormone therapies for menopause. Founded in 2008 in Boca Raton, Florida, after a medical-device entrepreneur and an obstetrician-gynecologist met in their neighborhood, the name pairs "therapeutics" with the co-founder's medical degree. The firm has since licensed its products to partners and now earns royalties on their sales.
Glickman Mark ACo-Chief Executive Officer · 2 transactions
—
1.7Kas of Dec 2022
1.7K
—
440
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +1.67M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.